Discovery

of new biopharmaceuticals and diagnostic agents

Discovery of new biopharmaceuticals and mAb based reagents utilising innovative methodologies in therapeutic and diagnostic mAb discovery, as well as the development of platform technologies for mAb delivery to intracellular targets.